Yawning induced by the selective dopamine D2 agonist N-0437 is blocked by the selective dopamine autoreceptor antagonist (+)-UH 232. 1989

S J Cooper, and I N Rusk, and D J Barber
School of Psychology, University of Birmingham, United Kingdom.

Yawning and stretching responses were elicited in rats by a small dose (0.3 mg/kg) of the highly selective dopamine D2 agonist, N-0437. The responses were blocked by the highly selective dopamine autoreceptor antagonist, (+)-UH 232 (3.0 mg/kg), but not by raclopride at a dose which selectively blocks postsynaptic D2 receptors. The results strongly confirm the view that yawning and stretching are behavioral responses elicited by stimulation of presynaptic D2 receptors.

UI MeSH Term Description Entries
D008297 Male Males
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012457 Salicylamides Amides of salicylic acid.
D013764 Tetrahydronaphthalenes Partially saturated 1,2,3,4-tetrahydronaphthalene compounds. Tetralins
D013876 Thiophenes A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur. Thiophene
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015000 Yawning An involuntary deep INHALATION with the MOUTH open, often accompanied by the act of stretching. Yawnings
D015259 Dopamine Agents Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. Dopamine Drugs,Dopamine Effect,Dopamine Effects,Dopaminergic Agents,Dopaminergic Drugs,Dopaminergic Effect,Dopaminergic Effects,Agents, Dopamine,Agents, Dopaminergic,Drugs, Dopamine,Drugs, Dopaminergic,Effect, Dopamine,Effect, Dopaminergic,Effects, Dopamine,Effects, Dopaminergic

Related Publications

S J Cooper, and I N Rusk, and D J Barber
January 1990, Synapse (New York, N.Y.),
S J Cooper, and I N Rusk, and D J Barber
January 1987, Psychopharmacology,
S J Cooper, and I N Rusk, and D J Barber
May 1988, Pharmaceutical research,
S J Cooper, and I N Rusk, and D J Barber
July 1990, European journal of pharmacology,
S J Cooper, and I N Rusk, and D J Barber
November 1986, European journal of pharmacology,
S J Cooper, and I N Rusk, and D J Barber
December 1989, Neuropharmacology,
S J Cooper, and I N Rusk, and D J Barber
November 1986, Naunyn-Schmiedeberg's archives of pharmacology,
S J Cooper, and I N Rusk, and D J Barber
October 1985, Pharmaceutisch weekblad. Scientific edition,
S J Cooper, and I N Rusk, and D J Barber
July 1994, European journal of pharmacology,
Copied contents to your clipboard!